Keyphrases
Population-based Study
100%
United States
100%
Elderly Patients
100%
Lung Cancer Treatment
100%
Timely Care
100%
Lung Cancer Prognosis
100%
Delayed Diagnosis
50%
Delayed Care
50%
Mortality Risk
33%
Lung Cancer
33%
Time-to-treatment
33%
Lung Cancer Risk
33%
Quality of Cancer Care
33%
Confidence Interval
16%
Hazard Ratio
16%
Psychological Stress
16%
Non-associated
16%
Disease Progression
16%
Medicare
16%
Disease Risk
16%
Early Diagnosis
16%
Multivariable
16%
Non-small Cell Lung Cancer (NSCLC)
16%
Survival Outcomes
16%
Low-income
16%
Management Services
16%
White Race
16%
Medicare Beneficiaries
16%
Cox Proportional Hazards Model
16%
Treatment Delay
16%
Generalized Logistic Model
16%
Diagnostic Services
16%
RAND Corporation
16%
Log-rank Test
16%
Kaplan-Meier Analysis
16%
British Thoracic Society
16%
Lung Cancer Screening
16%
Surveillance Epidemiology
16%
Comorbidity Scores
16%
Better Prognosis
16%
Timeliness of Care
16%
Non-white
16%
Medicare Database
16%
Increasing Age
16%
Medicine and Dentistry
Elderly Patient
100%
Lung Cancer
100%
Medicare
37%
Malignant Neoplasm
25%
Cancer Mortality
25%
Disease
12%
Proportional Hazards Model
12%
Hazard Ratio
12%
Disease Exacerbation
12%
Mental Stress
12%
Log Rank Test
12%
Lung Cancer Diagnostics
12%
Kaplan Meier Method
12%
Surveillance, Epidemiology, and End Results
12%
Non-Small Cell Lung Cancer
12%
Comorbidity
12%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Malignant Neoplasm
22%
Cancer Mortality
22%
Disease
11%
Disease Exacerbation
11%
Comorbidity
11%